Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Ashfield, Health Unlimited and Ashley Communications add to their teams

The latest med comms movers

- PMLiVE

NICE U-turn on Crystiva for rare bone disease

Watchdog to back the drug to treat young people with XLH

- PMLiVE

Home-grown colorectal cancer drug approved in China

Major milestone for China's R&D-based companies

- PMLiVE

Joint Working That Works

Claire Munro blogs about a recent Dovetail workshop on best practice in collaboration between industry and the NHS.

Dovetail

- PMLiVE

PharmaTimes Sales Awards entry deadline approaching soon

Final call for entries as submission date nears

- PMLiVE

Redmile and Google help Evox raise £35.5m for exosome pipeline

It is reported that GV contributed £10m of the total

- PMLiVE

UK start-up Azeria emerges with £4m drug discovery pot for cancer

The company is focusing on hormone resistant breast and prostate cancer

- PMLiVE

Daily Brief: Another next-gen diabetes research deal for Novo, Vertex and Australia break deadlock

News from pharma, biotech and healthcare

Sanofi reception

Sanofi gets EU OK for Ablynx flagship drug Cablivi

EMA clears the drug to treat adults with aTTP

- PMLiVE

Darzalex powers ahead with frontline myeloma approval in Europe

New approval makes Darzalex first antibody drug approved in first line

- PMLiVE

MHRA cut out of regulatory work as Brexit looms

This year the regulatory body was only awarded two contracts to serve as the lead assessor on NDAs

- PMLiVE

Alnylam gets EU nod for Onpattro amid pricing backlash

However the drug’s price could be lowered in the EU due to direct competition

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links